Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients
Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients
批准号:
10464910
负责人:
Francisco J Pasquel
金额:
$19.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-20 至 2024-08-31
关键词:
AcuteAgeAgonistAmino AcidsAreaBeta CellBioinformaticsBiologicalBiological MarkersBlood GlucoseBody mass indexBranched-Chain Amino AcidsC-reactive proteinCardiac Surgery proceduresCardiovascular DiseasesCardiovascular systemCatabolismCell physiologyCellular StressCeramidesCessation of lifeClinicalClinical ResearchClinical TrialsCoagulation ProcessComplexCoronary Artery BypassDiabetes MellitusDimensionsDoseEndocrinologistEnvironmentExposure toFibrin split productsFunctional disorderFundingGLP-I receptorGlucagonGlucoseGlucose Metabolism DisordersGlycosylated hemoglobin AGoalsGrantHeat-Shock Proteins 70HormonesHospitalsHourHyperglycemiaHypoglycemiaIatrogenesisInflammationInflammation MediatorsInflammatory ResponseInfusion proceduresInpatientsInsulinInsulin ResistanceInternationalIntravenousKnowledgeLeadLearning SkillLength of StayLinkMeasurementMediatingMentored Patient-Oriented Research Career Development AwardMentorsMentorshipMetabolicMetabolic PathwayMetabolic stressMethodsNested Case-Control StudyOperative Surgical ProceduresOutcomePathway AnalysisPathway interactionsPatientsPerioperativePerioperative complicationPlacebosPostoperative PeriodPreventionPrevention therapyRandomizedResearchResearch DesignResearch PersonnelResearch Project GrantsResearch Project SummariesResearch ProposalsResolutionResourcesRiskStressTechniquesTestingTrainingUnited States National Institutes of HealthUniversitiesUrokinase Plasminogen Activator ReceptorWritingacylcarnitinebasebiomarker panelblood glucose regulationcardiovascular disorder riskcardiovascular risk factorcareercase controlcostdesignexperienceglycemic controlhigh riskimmunoregulationimprovedinflammatory markerinsightinsulin secretionlipid Imetabolic phenotypemetabolic profilemetabolomemetabolomicsminimal riskmortalitymultidisciplinarynon-diabeticnovelnovel strategiesnovel therapeuticsobese patientsperioperative mortalitypreventprimary endpointpublic health relevanceresponsesecondary endpointspecific biomarkersstress managementtooltranslational scientisttreatment choice
中文摘要
项目总结
英文摘要
Project Summary
Research: Stress hyperglycemia is common in the perioperative period and is associated with increased risk of
postoperative mortality. Counterregulatory hormones and inflammatory mediators appear to modulate the acute
biological response to stress; however, the pathophysiological pathways that result in stress hyperglycemia and
its link to poor clinical outcomes are not well understood. Comprehensive metabolic profiling (metabolomics)
represents a novel tool to examine metabolic changes during stress conditions. The current approach to treat
hyperglycemia with insulin has major limitations including high resource utilization and high risk of hypoglycemia.
The overarching hypotheses of this research proposal are that: 1) Stress-hyperglycemia is associated with
changes in unknown and known metabolites (i.e. branched-chain amino acids, acylcarnitines, ceramides) and
path-specific biomarkers (representing inflammation,!coagulation, cell stress, and immune modulation) in the
perioperative period in cardiac surgery patients, and 2) with a low risk of iatrogenic hypoglycemia, exposure to a
long acting glucagon like peptide-1 receptor agonist (GLP-1 RA) will ameliorate the hyperglycemic and
inflammatory response to surgical stress. Using comprehensive metabolic profiling methods, this study will
provide new insights into the mechanisms underlying the metabolic and inflammatory responses to surgical stress
(Aim 1). This study will also examine whether exposure to a long acting GLP-1 RA can improve glycemic control
and ameliorate the inflammatory response to acute surgical stress (Aim 2). These findings will provide proof-of
principle to support the use of novel therapies to prevent and manage stress hyperglycemia in the inpatient
setting. Candidate and Environment: The candidate for this K23 award is Francisco J Pasquel, MD, MPH, a
highly qualified endocrinologist at Emory University committed to developing a career as an independently funded
translational researcher. The goal of this proposal is to provide the candidate with additional advanced mentored
training to develop expertise in mechanistic aspects of the metabolic response to stress and the design and
execution of complex clinical studies. Key components of the training plan include: 1) mentorship from
investigators with expertise in metabolomics, biomarkers, and clinical trials; 2) learning skills in bioinformatics,
metabolomics!and network analysis, and grant writing through advanced coursework; 3) hands-on experience
metabolomics research, and design/execution of a nested case-control study and a clinical trial; and 4)
participation in scholarly activities to develop independent research projects, and formulate NIH applications. To
successfully achieve his goals, the candidate has assembled a multidisciplinary and committed group of Mentors,
all of whom have successfully mentored junior investigators, have a strong track record of independent funding,
and are internationally recognized experts in all areas of research related to this project. The project will take
place at Emory University, a highly collaborative academic environment that provides an ideal setting to support
Dr. Pasquel's training and research needs.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.jcte.2021.100265
发表时间:
2021-12
期刊:
Journal of clinical & translational endocrinology
影响因子:
3
作者:
[Lopez-Huamanrayme E, Garate-Chirinos DD, Espinoza-Morales F, Del-Castillo-Ochoa S, Gomez-Noronha A, Salsavilca-Macavilca E, Taype-Rondan A, Pasquel FJ]
通讯作者:
Pasquel FJ
Web Exclusive. Annals for Hospitalists Inpatient Notes - How We Treat Hyperglycemia in the Hospital.
网络独家。
DOI:
10.7326/m21-2789
发表时间:
2021
期刊:
Annals of internal medicine
影响因子:
39.2
作者:
[Pasquel,FranciscoJ, Umpierrez,GuillermoE]
通讯作者:
Umpierrez,GuillermoE
Ectopic ACTH Syndrome With Association of Multiple Pulmonary Sclerosing Pneumocytomas and Multiple Carcinoid Tumorlets.
异位 ACTH 综合征与多发性肺硬化性肺细胞瘤和多发性类癌肿瘤相关。
DOI:
10.1210/js.2018-00334
发表时间:
2019
期刊:
Journal of the Endocrine Society
影响因子:
4.1
作者:
[Benito-Martínez,Estela, Galeano-Valle,Francisco, González,Adriana, Edgar,MarkA, Oprea-Ilies,Gabriela, Ioachimescu,AdrianaG, Pasquel,FranciscoJ]
通讯作者:
Pasquel,FranciscoJ
Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients
-
批准号:10242186
-
项目类别:
-
资助金额:$19.15万
-
财政年份:2018
-
负责人:Francisco J Pasquel
-
依托单位:
Technologies Advancing Translation and Equity - Regional Core
-
批准号:10290784
-
项目类别:
-
资助金额:$17.17万
-
财政年份:2016
-
负责人:Francisco J Pasquel
-
依托单位:
Technologies Advancing Translation and Equity - Regional Core
-
批准号:10470281
-
项目类别:
-
资助金额:$17.68万
-
财政年份:2016
-
负责人:Francisco J Pasquel
-
依托单位:
Technologies Advancing Translation and Equity - Regional Core
-
批准号:10693151
-
项目类别:
-
资助金额:$16.08万
-
财政年份:2016
-
负责人:Francisco J Pasquel
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: